Delanzomib

• Description :

  A potent, orally active proteasome inhibitor with IC50 of 3.8 nM against chymotrypsin-like proteasome activity.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  413.2751

• Molecular Formula :

  C21H28BN3O5

• Notes :

  Research use only, not for human use.

• Receptor :

  Chymotrypsin-likeproteasome

• CAS Number :

  847499-27-8